Mécanismes et prévention de la dégénérescence axonale dans les neuropathies dysimmunitaires

It is increasingly difficult to propose new treatments with validated efficiency, due to the small number of patients presenting dysimmune neuropathies of the type discussed here that are both typical and suitable for inclusion in medium to long term studies.